[{"NetIncomeLoss_3_Q3_USD":-4352000000.0,"RestructuringCharges_1_Q3_USD":-6000000.0,"RestructuringCharges_3_Q3_USD":80000000.0,"AssetsCurrent_0_Q3_USD":25848000000.0,"GoodwillForeignCurrencyTranslationGainLoss_3_Q3_USD":-34000000.0,"OtherBorrowings_0_Q3_USD":14000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-249000000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":3435000000.0,"PaymentsForRestructuring_3_Q3_USD":58000000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_3_Q3_USD":12000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-141000000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q3_USD":772000000.0,"RepaymentsOfLongTermDebt_3_Q3_USD":888000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":442000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":63.96,"CommonStockDividendsPerShareDeclared_1_Q3_USD":0.4811,"CommonStockDividendsPerShareDeclared_3_Q3_USD":1.4433,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q3_USD":5000000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q3_USD":22000000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":1165000000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":110955000000.0,"StockholdersEquityOther_3_Q3_USD":-1000000.0,"StockholdersEquityOther_1_Q3_USD":-2000000.0,"ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_0_Q3_pure":0.1,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-38000000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-62000000.0,"Assets_0_Q3_USD":41148000000.0,"CommonStockSharesIssued_0_Q3_shares":327000000.0,"UnrecognizedTaxBenefits_0_Q3_USD":919000000.0,"FinanceLeaseLiabilityNoncurrent_0_Q3_USD":10000000.0,"GainLossRelatedToLitigationSettlement_1_Q3_USD":-35000000.0,"LongTermDebtAndCapitalLeaseObligationsCurrent_0_Q3_USD":508000000.0,"TreasuryStockValue_0_Q3_USD":2086000000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":35000000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_3_Q3_USD":65000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":4000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":7000000.0,"TreasuryStockShares_0_Q3_shares":35000000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":37272000000.0,"GainLossRelatedToLitigationSettlement_3_Q3_USD":-5729000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q3_USD":1000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":2000000.0,"ProvisionForDoubtfulAccounts_3_Q3_USD":86000000.0,"Revenues_3_Q3_USD":116233000000.0,"Revenues_1_Q3_USD":39157000000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_3_Q3_USD":-1000000.0,"CommonStockValue_0_Q3_USD":2774000000.0,"NumberOfReportableSegments_3_Q3_segment":2.0,"IncomeTaxExpenseBenefit_1_Q3_USD":127000000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-237000000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-19000000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q3_USD":137000000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-21000000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q3_USD":-5000000.0,"RestructuringCosts_3_Q3_USD":67000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":294000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":293000000.0,"FinanceLeasePrincipalPayments_3_Q3_USD":4000000.0,"MinorityInterest_0_Q3_USD":3000000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":2805000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":64.02,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":-9000000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":688000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3_Q3_shares":0.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q3_USD":5844000000.0,"IncreaseDecreaseInReceivables_3_Q3_USD":653000000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_3_Q3_USD":-5425000000.0,"OperatingLeaseLiability_0_Q3_USD":490000000.0,"Dividends_1_Q3_USD":142000000.0,"Dividends_3_Q3_USD":426000000.0,"FinanceLeaseLiability_0_Q3_USD":14000000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":381000000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":2329000000.0,"OtherAssetsNoncurrent_0_Q3_USD":1623000000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":129000000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":385000000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":448000000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":312000000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-4414000000.0,"IncreaseDecreaseInInventories_3_Q3_USD":8000000.0,"OtherAssetsCurrent_0_Q3_USD":1692000000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-1672000000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.268,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.052,"ShareBasedCompensation_3_Q3_USD":68000000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":469000000.0,"ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_1_Q3_USD":0.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_3_Q3_USD":0.0,"SeveranceCosts1_1_Q3_USD":-15000000.0,"SeveranceCosts1_3_Q3_USD":47000000.0,"InterestExpense_1_Q3_USD":60000000.0,"InterestExpense_3_Q3_USD":189000000.0,"AccountsPayableCurrent_0_Q3_USD":21984000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":-202000000.0,"LiabilitiesCurrent_0_Q3_USD":24671000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":292000000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":2179000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":293000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":-17000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":-35000000.0,"LongTermDebtAndCapitalLeaseObligations_0_Q3_USD":6754000000.0,"Goodwill_0_Q3_USD":8339000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":-62000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-38000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":408000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":358000000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":1720000000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":3039000000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_3_Q3_USD":-14.84,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q3_USD":1.19,"NetIncomeLoss_1_Q3_USD":350000000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2299000000.0,"ReceivablesNetCurrent_0_Q3_USD":9019000000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"GainLossOnSalesOfAssetsAndAssetImpairmentCharges_1_Q3_USD":1000000.0,"GainLossOnSalesOfAssetsAndAssetImpairmentCharges_3_Q3_USD":-7000000.0,"OperatingLeasePayments_3_Q3_USD":95000000.0,"NumberOfOperatingSegments_3_Q3_segment":2.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":3017000000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":0.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":1206000000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_3_Q3_shares":0.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q3_shares":2000000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.028,"FinanceLeaseRightOfUseAssetAmortization_1_Q3_USD":1000000.0,"FinanceLeaseRightOfUseAssetAmortization_3_Q3_USD":9000000.0,"PaymentsOfDividendsCommonStock_3_Q3_USD":428000000.0,"GrossProfit_1_Q3_USD":1885000000.0,"GrossProfit_3_Q3_USD":5278000000.0,"DeferredTaxAndOtherLiabilitiesNoncurrent_0_Q3_USD":8517000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":313000000.0,"LeaseCost_1_Q3_USD":37000000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":656000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":68000000.0,"PreferredStockSharesAuthorized_0_Q3_shares":500000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":41148000000.0,"OperatingLeaseCost_1_Q3_USD":31000000.0,"OperatingLeaseCost_3_Q3_USD":92000000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":0.0,"PreferredStockValue_0_Q3_USD":0.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":5822000000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":27000000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":0.0,"RestructuringReserve_0_Q3_USD":81000000.0,"InventoryNet_0_Q3_USD":12808000000.0,"PaymentsForRepurchaseOfCommonStock_3_Q3_USD":350000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q3_USD":478000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q3_USD":-4587000000.0,"OperatingIncomeLoss_3_Q3_USD":-4368000000.0,"OperatingIncomeLoss_1_Q3_USD":562000000.0,"CommonStockSharesAuthorized_0_Q3_shares":755000000.0,"LossOnSaleOfInvestments_3_Q3_USD":0.0,"FinanceLeaseRightOfUseAsset_0_Q3_USD":13000000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":109000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":134000000.0,"OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_1_Q3_USD":-21000000.0,"OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_3_Q3_USD":-27000000.0,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q3_USD":1.2,"IncomeLossFromContinuingOperationsPerBasicShare_3_Q3_USD":-14.84,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":5000000.0,"VariableLeaseCost_3_Q3_USD":17000000.0,"VariableLeaseCost_1_Q3_USD":5000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":6000000.0,"GoodwillTransfers_3_Q3_USD":-5000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q3_USD":328000000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q3_USD":11378000000.0,"ProceedsFromRepaymentsOfShortTermDebt_3_Q3_USD":-2000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":239000000.0,"StockholdersEquity_0_Q3_USD":1203000000.0,"FinanceLeaseLiabilityCurrent_0_Q3_USD":4000000.0,"ProfitLoss_1_Q3_USD":351000000.0,"ProfitLoss_3_Q3_USD":-4350000000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":154000000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_3_Q3_USD":17000000.0,"LeaseCost_3_Q3_USD":118000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-4412000000.0,"Ticker":"CAH","CIK":"721371","name":"CARDINAL HEALTH INC","OfficialName":"Cardinal Health Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"17377290506.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"SP500","filed":"20200511"}]